J. Safra Sarasin Holding AG Reduces Stock Position in Agilent Technologies, Inc. $A

J. Safra Sarasin Holding AG decreased its position in Agilent Technologies, Inc. (NYSE:A) by 11.9% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 158,835 shares of the medical research company’s stock after selling 21,484 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Agilent Technologies were worth $18,100,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC grew its holdings in shares of Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after buying an additional 270 shares in the last quarter. Jones Financial Companies Lllp raised its position in shares of Agilent Technologies by 15.9% in the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after buying an additional 769 shares during the last quarter. Geneos Wealth Management Inc. lifted its stake in shares of Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after buying an additional 212 shares during the period. Acadian Asset Management LLC lifted its stake in shares of Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after buying an additional 758 shares during the period. Finally, Sivia Capital Partners LLC acquired a new stake in Agilent Technologies during the second quarter worth approximately $273,000. 87.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Wells Fargo & Company reduced their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. Royal Bank Of Canada started coverage on Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price objective on the stock. Sanford C. Bernstein started coverage on Agilent Technologies in a research report on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective for the company. Finally, HSBC dropped their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $159.35.

Agilent Technologies Stock Performance

NYSE:A opened at $134.57 on Monday. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The company has a market cap of $38.01 billion, a P/E ratio of 27.02, a P/E/G ratio of 2.39 and a beta of 1.25. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The firm’s 50 day moving average is $125.75 and its two-hundred day moving average is $125.68.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The company had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts expect that Agilent Technologies, Inc. will post 6 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.